Stem Cell Therapy is Going to the Dogs!
Translational Applications from Canine to Human Patients
Richard Vulliet, DVM, PhD
Professor of Molecular Biosciences
U.C. Davis School of Veterinary Medicine
Tuesday, October 28th
6:00 - 7:00 pm
University Union, Ballroom Room 1
The Sacramento State STEM Public Lecture Series welcomes Dr. Richard Vulliet, professor at UC Davis’ School of Veterinary Medicine. His talk titled "Stem Cell Therapy is Going to the Dogs!" will address his current research focused on canine stem cell therapy.
Utilizing dog patients can help speed the investigation of novel therapies that may translate into technologies and treatments that apply to human diseases. Diseases being tested for response to stem cell therapy include degenerative myelopathy (a canine form of human familial ALS), dilated cardiomyopathy, idiopathic pulmonary fibrosis, and early onset Parkinson’s disease. In pilot dogs, these widely disparate diseases all appear to benefit from stem cell therapy, suggesting that the cells may work through multiple therapeutic mechanisms. If therapeutic benefit is proven, a dog patient can be so much more than “a human patient’s best friend.”
Dr. Richard Vulliet, a professor at UC Davis’ School of Veterinary Medicine, received his PhD at the University of Colorado, Denver, and his DVM at Colorado State University, Fort Collins. Dr. Vulliet has received numerous awards for his work and is the founder of ReGena-Vet Laboratories, LLC.
|Regenerative Medicine Lecture Series
Dr. Rosalee Sprowls
Office phone: (916) 278-7391
STEM Scholars Series
Coordinator, Center for STEM Excellence